15769913

Source:http://linkedlifedata.com/resource/pubmed/id/15769913

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0017262, umls-concept:C0025677, umls-concept:C0185117, umls-concept:C0205210, umls-concept:C0205216, umls-concept:C0205269, umls-concept:C0242708, umls-concept:C0332281, umls-concept:C0383327, umls-concept:C0666743, umls-concept:C1332817, umls-concept:C1456820, umls-concept:C1550315, umls-concept:C2911684
pubmed:issue	4
pubmed:dateCreated	2005-3-16
pubmed:abstractText	Tumour necrosis alpha (TNF alpha) blocking agents lead to pronounced clinical effects and reduced synovial infiltrate in rheumatoid arthritis. Laboratory and clinical studies suggest that TNF alpha independent pathways play a role in the disease.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-10075615, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-10088597, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-10622295, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-10643698, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-11083259, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-11086103, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-11096166, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-11466388, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-11817585, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-11920421, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-12117680, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-12384916, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-12571842, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-12574387, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-12695163, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-12832715, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-12847274, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-13130466, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-15001324, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-15082477, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-3358796, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-8250987, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-8546736, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-8670314, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-8759892, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-9041933, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-9449707, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769913-9651076
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/CXCL12 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL12, http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CXC, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18, http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0003-4967
pubmed:author	pubmed-author:HuizingaT W JTW, pubmed-author:LevarhtE W NEW, pubmed-author:ShubT ATA, pubmed-author:ToesR E MRE, pubmed-author:van LaarJ MJM, pubmed-author:van OosterhoutMM
pubmed:issnType	Print
pubmed:volume	64
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	537-43
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:15769913-Adult, pubmed-meshheading:15769913-Antibodies, Monoclonal, pubmed-meshheading:15769913-Antirheumatic Agents, pubmed-meshheading:15769913-Arthritis, Rheumatoid, pubmed-meshheading:15769913-Arthroscopy, pubmed-meshheading:15769913-Chemokine CXCL12, pubmed-meshheading:15769913-Chemokines, CXC, pubmed-meshheading:15769913-Drug Therapy, Combination, pubmed-meshheading:15769913-Female, pubmed-meshheading:15769913-Humans, pubmed-meshheading:15769913-Immunoenzyme Techniques, pubmed-meshheading:15769913-Interleukin-18, pubmed-meshheading:15769913-Ligands, pubmed-meshheading:15769913-Male, pubmed-meshheading:15769913-Methotrexate, pubmed-meshheading:15769913-Middle Aged, pubmed-meshheading:15769913-Synovial Membrane, pubmed-meshheading:15769913-Synovitis, pubmed-meshheading:15769913-Treatment Failure, pubmed-meshheading:15769913-Treatment Outcome, pubmed-meshheading:15769913-Tumor Necrosis Factor-alpha
pubmed:year	2005
pubmed:articleTitle	Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
pubmed:affiliation	Leiden University Medical Centre, Department of Rheumatology, PO Box 9600, 2300 RC Leiden, Netherlands. M.van_Oosterhout@LUMC.nl
pubmed:publicationType	Journal Article

More...